{"id":"https://openalex.org/W4396599092","doi":"https://doi.org/10.1158/1538-7445.sabcs23-ps11-05","title":"Abstract PS11-05: Trastuzumab Deruxtecan in patients with HER2[+] or HER2-Low Advanced Breast Cancer and Pathologically Confirmed Leptomeningeal Carcinomatosis: Results from Cohort 5 of the DEBBRAH Study","display_name":"Abstract PS11-05: Trastuzumab Deruxtecan in patients with HER2[+] or HER2-Low Advanced Breast Cancer and Pathologically Confirmed Leptomeningeal Carcinomatosis: Results from Cohort 5 of the DEBBRAH Study","publication_year":2024,"publication_date":"2024-05-02","ids":{"openalex":"https://openalex.org/W4396599092","doi":"https://doi.org/10.1158/1538-7445.sabcs23-ps11-05"},"language":"en","primary_location":{"id":"doi:10.1158/1538-7445.sabcs23-ps11-05","doi":"https://doi.org/10.1158/1538-7445.sabcs23-ps11-05","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.sabcs23-ps11-05","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5053861062","display_name":"Marta Vaz Batista","orcid":"https://orcid.org/0000-0001-5791-2092","observed_orcids":["https://orcid.org/0000-0001-5791-2092"]},"institutions":[{"id":"https://openalex.org/I4210099144","display_name":"Hospital Prof. Dr. Fernando Fonseca","ror":"https://ror.org/010bsbc18","country_code":"PT","type":"healthcare","lineage":["https://openalex.org/I4210099144"]},{"id":"https://openalex.org/I4210102398","display_name":"MedSIR (Spain)","ror":"https://ror.org/00t6sz979","country_code":"ES","type":"company","lineage":["https://openalex.org/I4210102398"]}],"countries":["ES","PT"],"is_corresponding":false,"raw_author_name":"Marta Vaz Batista","raw_affiliation_strings":["1Hospital Professor Doutor Fernando Fonseca EPE, Lisbon, Portugal. Medica Scientia Innovation Research (MEDSIR), Barcelona, Spain and Ridgewood, New Jersey, US., Amadora , Lisboa, Portugal;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Hospital Professor Doutor Fernando Fonseca EPE, Lisbon, Portugal. Medica Scientia Innovation Research (MEDSIR), Barcelona, Spain and Ridgewood, New Jersey, US., Amadora , Lisboa, Portugal;","institution_ids":["https://openalex.org/I4210099144","https://openalex.org/I4210102398"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5090108117","display_name":"Jos\u00e9 Manuel P\u00e9rez-Garc\u00eda","orcid":"https://orcid.org/0000-0003-4238-2046","observed_orcids":["https://orcid.org/0000-0003-4238-2046","https://orcid.org/0009-0004-2204-2014"]},"institutions":[{"id":"https://openalex.org/I4210102398","display_name":"MedSIR (Spain)","ror":"https://ror.org/00t6sz979","country_code":"ES","type":"company","lineage":["https://openalex.org/I4210102398"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Jos\u00e9 Manuel P\u00e9rez-Garc\u00eda","raw_affiliation_strings":["2Innternational Breast Cancer Center (IBCC), Pangaea Oncology, Quiron Group, Barcelona, Spain; Medica Scientia Innovation Research (MEDSIR), Barcelona, Spain and Ridgewood, New Jersey, US., Catalonia, Spain;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Innternational Breast Cancer Center (IBCC), Pangaea Oncology, Quiron Group, Barcelona, Spain; Medica Scientia Innovation Research (MEDSIR), Barcelona, Spain and Ridgewood, New Jersey, US., Catalonia, Spain;","institution_ids":["https://openalex.org/I4210102398"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5024818826","display_name":"Laia Garrig\u00f3s","orcid":"https://orcid.org/0009-0006-4865-227X","observed_orcids":["https://orcid.org/0009-0006-4865-227X"]},"institutions":[{"id":"https://openalex.org/I4210096255","display_name":"Hospital Universitario Dexeus","ror":"https://ror.org/00scfzf83","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4210096255"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Laia Garrig\u00f3s","raw_affiliation_strings":["3International Breast Cancer Center (IBCC), Quiron Group, Barcelona, Spain. Hospital Universitari Dexeus, Spain;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"3International Breast Cancer Center (IBCC), Quiron Group, Barcelona, Spain. Hospital Universitari Dexeus, Spain;","institution_ids":["https://openalex.org/I4210096255"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5029469753","display_name":"Jos\u00e9 \u00c1. Garc\u00eda-S\u00e1enz","orcid":"https://orcid.org/0000-0001-6880-0301","observed_orcids":["https://orcid.org/0000-0001-6880-0301"]},"institutions":[{"id":"https://openalex.org/I2961216182","display_name":"Hospital Cl\u00ednico San Carlos","ror":"https://ror.org/04d0ybj29","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I2961216182","https://openalex.org/I4210139293"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Jos\u00e9 \u00c1ngel Garc\u00eda-S\u00e1enz","raw_affiliation_strings":["4Hospital Cl\u00ednico San Carlos, Madrid, Spain;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"4Hospital Cl\u00ednico San Carlos, Madrid, Spain;","institution_ids":["https://openalex.org/I2961216182"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5058940619","display_name":"Patricia Cortez-Castedo","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210150844","display_name":"Hospital Ruber Internacional","ror":"https://ror.org/04abjq359","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4210150844"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Patricia Cortez-Castedo","raw_affiliation_strings":["5IOB Institute of Oncology, Hospital Ruber Internacional, Quiron Group, Spain;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"5IOB Institute of Oncology, Hospital Ruber Internacional, Quiron Group, Spain;","institution_ids":["https://openalex.org/I4210150844"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5002822174","display_name":"Fabriccio Racca","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Fabriccio Racca","raw_affiliation_strings":["6IOB Institute of Oncology, Quiron Group, Spain;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"6IOB Institute of Oncology, Quiron Group, Spain;","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112899140","display_name":"Salvador Blanch","orcid":"https://orcid.org/0009-0008-9553-2179","observed_orcids":["https://orcid.org/0009-0008-9553-2179"]},"institutions":[{"id":"https://openalex.org/I4210102398","display_name":"MedSIR (Spain)","ror":"https://ror.org/00t6sz979","country_code":"ES","type":"company","lineage":["https://openalex.org/I4210102398"]},{"id":"https://openalex.org/I4210103093","display_name":"Fundaci\u00f3n Instituto Valenciano de Oncolog\u00eda","ror":"https://ror.org/01fh9k283","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4210103093"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Salvador Blanch","raw_affiliation_strings":["7Mndica Scientia Innovation Research (MEDSIR), Barcelona, Spain and Ridgewood, New Jersey, US. Fundaci\u00f3n Instituto Valenciano de Oncolog\u00eda, Valencia, Spain;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"7Mndica Scientia Innovation Research (MEDSIR), Barcelona, Spain and Ridgewood, New Jersey, US. Fundaci\u00f3n Instituto Valenciano de Oncolog\u00eda, Valencia, Spain;","institution_ids":["https://openalex.org/I4210102398","https://openalex.org/I4210103093"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111876641","display_name":"Manuel Ru\u00edz Borrego","orcid":"https://orcid.org/0000-0002-1181-5622","observed_orcids":["https://orcid.org/0000-0002-1181-5622"]},"institutions":[{"id":"https://openalex.org/I4210153139","display_name":"Hospital Universitario Virgen del Roc\u00edo","ror":"https://ror.org/04vfhnm78","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4210153139"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Manuel Ru\u00edz - Borrego","raw_affiliation_strings":["8Hospital Universitario Virgen del Rocio, Sevilla, Andalucia, Spain;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"8Hospital Universitario Virgen del Rocio, Sevilla, Andalucia, Spain;","institution_ids":["https://openalex.org/I4210153139"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Adela Fern\u00e1ndez","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I189268942","display_name":"Universidad de Alcal\u00e1","ror":"https://ror.org/04pmn0e78","country_code":"ES","type":"education","lineage":["https://openalex.org/I189268942"]},{"id":"https://openalex.org/I4210161852","display_name":"Hospital Universitario Ram\u00f3n y Cajal","ror":"https://ror.org/050eq1942","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4210139293","https://openalex.org/I4210161852"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Adela Fern\u00e1ndez","raw_affiliation_strings":["9Medical Oncology Department, Hospital Ramon y Cajal, Madrid, Spain; Alcal\u00e1 de Henares University, Faculty of Medicine, Spain;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"9Medical Oncology Department, Hospital Ramon y Cajal, Madrid, Spain; Alcal\u00e1 de Henares University, Faculty of Medicine, Spain;","institution_ids":["https://openalex.org/I189268942","https://openalex.org/I4210161852"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100753627","display_name":"Mar\u00eda Fern\u00e1ndez-Abad","orcid":"https://orcid.org/0000-0002-4382-4726","observed_orcids":["https://orcid.org/0000-0002-4382-4726"]},"institutions":[{"id":"https://openalex.org/I189268942","display_name":"Universidad de Alcal\u00e1","ror":"https://ror.org/04pmn0e78","country_code":"ES","type":"education","lineage":["https://openalex.org/I189268942"]},{"id":"https://openalex.org/I4210161852","display_name":"Hospital Universitario Ram\u00f3n y Cajal","ror":"https://ror.org/050eq1942","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4210139293","https://openalex.org/I4210161852"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Mar\u00eda Fern\u00e1ndez-Abad","raw_affiliation_strings":["10nospital Universitario Ram\u00f3n y Cajal, Madrid (Spain); Universitad de Alcal\u00e1 de Henares, ONCARE, Spain;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"10nospital Universitario Ram\u00f3n y Cajal, Madrid (Spain); Universitad de Alcal\u00e1 de Henares, ONCARE, Spain;","institution_ids":["https://openalex.org/I189268942","https://openalex.org/I4210161852"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5070887037","display_name":"Vega Iranzo","orcid":"https://orcid.org/0000-0001-6183-5173","observed_orcids":["https://orcid.org/0000-0001-6183-5173"]},"institutions":[{"id":"https://openalex.org/I4210127649","display_name":"Hospital General Universitario De Valencia","ror":"https://ror.org/03sz8rb35","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4210127649"]},{"id":"https://openalex.org/I4210163263","display_name":"GEICAM \u2013 Spanish Breast Cancer Group","ror":"https://ror.org/05ygm7711","country_code":"ES","type":"nonprofit","lineage":["https://openalex.org/I4210163263"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Vega Iranzo","raw_affiliation_strings":["11Hospital General Universitario de Valencia. GEICAM Spanish Breast Cancer Group, Spain;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"11Hospital General Universitario de Valencia. GEICAM Spanish Breast Cancer Group, Spain;","institution_ids":["https://openalex.org/I4210127649","https://openalex.org/I4210163263"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5031395305","display_name":"Mar\u00eda Gi\u00f3n","orcid":"https://orcid.org/0000-0002-6601-3360","observed_orcids":["https://orcid.org/0000-0002-6601-3360"]},"institutions":[{"id":"https://openalex.org/I4210161852","display_name":"Hospital Universitario Ram\u00f3n y Cajal","ror":"https://ror.org/050eq1942","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4210139293","https://openalex.org/I4210161852"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Maria Gion","raw_affiliation_strings":["12nam\u00f3n y Cajal University Hospital, Madrid, Madrid, Spain;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"12nam\u00f3n y Cajal University Hospital, Madrid, Madrid, Spain;","institution_ids":["https://openalex.org/I4210161852"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5031344297","display_name":"Griselda Martrat","orcid":"https://orcid.org/0009-0005-8118-3615","observed_orcids":["https://orcid.org/0009-0005-8118-3615"]},"institutions":[{"id":"https://openalex.org/I4210102398","display_name":"MedSIR (Spain)","ror":"https://ror.org/00t6sz979","country_code":"ES","type":"company","lineage":["https://openalex.org/I4210102398"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Griselda Martrat","raw_affiliation_strings":["13Mndica Scientia Innovation Research (MEDSIR), Barcelona, Spain and Ridgewood, New Jersey, US., Barcelona, Catalonia, Spain;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"13Mndica Scientia Innovation Research (MEDSIR), Barcelona, Spain and Ridgewood, New Jersey, US., Barcelona, Catalonia, Spain;","institution_ids":["https://openalex.org/I4210102398"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5003876132","display_name":"Daniel Alcal\u00e1-L\u00f3pez","orcid":"https://orcid.org/0000-0003-2184-1346","observed_orcids":["https://orcid.org/0000-0003-2184-1346"]},"institutions":[{"id":"https://openalex.org/I4210102398","display_name":"MedSIR (Spain)","ror":"https://ror.org/00t6sz979","country_code":"ES","type":"company","lineage":["https://openalex.org/I4210102398"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Daniel Alcal\u00e1-L\u00f3pez","raw_affiliation_strings":["13Mndica Scientia Innovation Research (MEDSIR), Barcelona, Spain and Ridgewood, New Jersey, US., Barcelona, Catalonia, Spain;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"13Mndica Scientia Innovation Research (MEDSIR), Barcelona, Spain and Ridgewood, New Jersey, US., Barcelona, Catalonia, Spain;","institution_ids":["https://openalex.org/I4210102398"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5048785159","display_name":"Jhudit P\u00e9rez\u2010Escuredo","orcid":"https://orcid.org/0009-0009-1691-1849","observed_orcids":["https://orcid.org/0009-0009-1691-1849"]},"institutions":[{"id":"https://openalex.org/I4210102398","display_name":"MedSIR (Spain)","ror":"https://ror.org/00t6sz979","country_code":"ES","type":"company","lineage":["https://openalex.org/I4210102398"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Jhudit P\u00e9rez-Escuredo","raw_affiliation_strings":["13Mndica Scientia Innovation Research (MEDSIR), Barcelona, Spain and Ridgewood, New Jersey, US., Barcelona, Catalonia, Spain;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"13Mndica Scientia Innovation Research (MEDSIR), Barcelona, Spain and Ridgewood, New Jersey, US., Barcelona, Catalonia, Spain;","institution_ids":["https://openalex.org/I4210102398"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5082318397","display_name":"Miguel Sampayo-Cordero","orcid":"https://orcid.org/0000-0003-1469-3410","observed_orcids":["https://orcid.org/0000-0003-1469-3410"]},"institutions":[{"id":"https://openalex.org/I4210102398","display_name":"MedSIR (Spain)","ror":"https://ror.org/00t6sz979","country_code":"ES","type":"company","lineage":["https://openalex.org/I4210102398"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Miguel Sampayo-Cordero","raw_affiliation_strings":["13Mndica Scientia Innovation Research (MEDSIR), Barcelona, Spain and Ridgewood, New Jersey, US., Barcelona, Catalonia, Spain;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"13Mndica Scientia Innovation Research (MEDSIR), Barcelona, Spain and Ridgewood, New Jersey, US., Barcelona, Catalonia, Spain;","institution_ids":["https://openalex.org/I4210102398"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5030451537","display_name":"Antonio Llombart\u2010Cussac","orcid":"https://orcid.org/0000-0003-4515-8293","observed_orcids":["https://orcid.org/0000-0003-4515-8293"]},"institutions":[{"id":"https://openalex.org/I4210102398","display_name":"MedSIR (Spain)","ror":"https://ror.org/00t6sz979","country_code":"ES","type":"company","lineage":["https://openalex.org/I4210102398"]},{"id":"https://openalex.org/I4210119293","display_name":"Hospital Arnau de Vilanova","ror":"https://ror.org/02s7fkk92","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4210119293"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Antonio Llombart-Cussac","raw_affiliation_strings":["14Arnau de Vilanova Hospital, Valencia, Spain; Medica Scientia Innovation Research (MEDSIR), Barcelona, Spain and Ridgewood, New Jersey, US, Comunidad Valenciana, Spain;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"14Arnau de Vilanova Hospital, Valencia, Spain; Medica Scientia Innovation Research (MEDSIR), Barcelona, Spain and Ridgewood, New Jersey, US, Comunidad Valenciana, Spain;","institution_ids":["https://openalex.org/I4210102398","https://openalex.org/I4210119293"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5024784028","display_name":"Sofia Azambuja Braga","orcid":"https://orcid.org/0000-0002-3163-0174","observed_orcids":["https://orcid.org/0000-0002-3163-0174"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Sof\u00eda Braga","raw_affiliation_strings":["15nospital Professor Doutor Fernando Fonseca EPE, Lisbon, Portugal;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"15nospital Professor Doutor Fernando Fonseca EPE, Lisbon, Portugal;","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5051629490","display_name":"Javier Cort\u00e9s","orcid":"https://orcid.org/0000-0001-7623-1583","observed_orcids":["https://orcid.org/0000-0001-7623-1583"]},"institutions":[{"id":"https://openalex.org/I4210102398","display_name":"MedSIR (Spain)","ror":"https://ror.org/00t6sz979","country_code":"ES","type":"company","lineage":["https://openalex.org/I4210102398"]},{"id":"https://openalex.org/I904013037","display_name":"Universidad Europea de Madrid","ror":"https://ror.org/04dp46240","country_code":"ES","type":"education","lineage":["https://openalex.org/I904013037"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Javier Cort\u00e9s","raw_affiliation_strings":["16International Breast Cancer Center (IBCC), Pangaea Oncology,\u202fQuiron\u202fGroup, Barcelona,\u202fSpain; Medica Scientia Innovation Research (MEDSIR), Barcelona, Spain and Ridgewood, New Jersey, US; Department of Medicine, Faculty of Biomedical and Health Sciences, Universidad Europea de Madrid, Madrid, Spain., Madrid, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"16International Breast Cancer Center (IBCC), Pangaea Oncology,\u202fQuiron\u202fGroup, Barcelona,\u202fSpain; Medica Scientia Innovation Research (MEDSIR), Barcelona, Spain and Ridgewood, New Jersey, US; Department of Medicine, Faculty of Biomedical and Health Sciences, Universidad Europea de Madrid, Madrid, Spain., Madrid, Spain","institution_ids":["https://openalex.org/I4210102398","https://openalex.org/I904013037"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":13,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":7,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"84","issue":"9_Supplement","first_page":"PS11","last_page":"05"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11600","display_name":"Brain Metastases and Treatment","score":0.8428000211715698,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11600","display_name":"Brain Metastases and Treatment","score":0.8428000211715698,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10755","display_name":"HER2/EGFR in Cancer Research","score":0.11320000141859055,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10417","display_name":"Lung Cancer Treatments and Mutations","score":0.007300000172108412,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/trastuzumab-deruxtecan","display_name":"trastuzumab deruxtecan","score":0.9990000128746033},{"id":"https://openalex.org/keywords/leptomeningeal-metastasis","display_name":"leptomeningeal metastasis","score":0.9629999995231628},{"id":"https://openalex.org/keywords/her2-positive-breast-cancer","display_name":"HER2-positive breast cancer","score":0.9639999866485596},{"id":"https://openalex.org/keywords/her2-low-breast-cancer","display_name":"HER2-low breast cancer","score":0.996999979019165},{"id":"https://openalex.org/keywords/advanced-breast-cancer","display_name":"advanced breast cancer","score":0.8880000114440918},{"id":"https://openalex.org/keywords/brain-metastases","display_name":"brain metastases","score":0.9570000171661377},{"id":"https://openalex.org/keywords/antibody-drug-conjugates","display_name":"antibody-drug conjugates","score":0.9340000152587891},{"id":"https://openalex.org/keywords/overall-survival","display_name":"overall survival","score":0.8349999785423279},{"id":"https://openalex.org/keywords/progression-free-survival","display_name":"progression-free survival","score":0.75},{"id":"https://openalex.org/keywords/cerebrospinal-fluid-cytology","display_name":"cerebrospinal fluid cytology","score":0.902999997138977},{"id":"https://openalex.org/keywords/intracranial-response","display_name":"intracranial response","score":0.6710000038146973},{"id":"https://openalex.org/keywords/safety-and-tolerability","display_name":"safety and tolerability","score":0.734000027179718},{"id":"https://openalex.org/keywords/metastatic-breast-cancer","display_name":"metastatic breast cancer","score":0.3409999907016754}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9087119698524475},{"id":"https://openalex.org/C2779786085","wikidata":"https://www.wikidata.org/wiki/Q412616","display_name":"Trastuzumab","level":4,"score":0.8808915615081787},{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.6617431640625},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.5560294985771179},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5188676118850708},{"id":"https://openalex.org/C72563966","wikidata":"https://www.wikidata.org/wiki/Q1303415","display_name":"Cohort","level":2,"score":0.5108861327171326},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.4516559839248657},{"id":"https://openalex.org/C126838900","wikidata":"https://www.wikidata.org/wiki/Q77604","display_name":"Radiology","level":1,"score":0.38306349515914917}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/1538-7445.sabcs23-ps11-05","doi":"https://doi.org/10.1158/1538-7445.sabcs23-ps11-05","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.sabcs23-ps11-05","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4402455352","https://openalex.org/W4322775125","https://openalex.org/W4220825543","https://openalex.org/W4401304375","https://openalex.org/W7220721428","https://openalex.org/W4401306179","https://openalex.org/W4411285529","https://openalex.org/W4361255817","https://openalex.org/W4401093589","https://openalex.org/W4281619692"],"abstract_inverted_index":{"Abstract":[0],"Background:":[1],"Leptomeningeal":[2,656],"carcinomatosis":[3],"(LMC)":[4],"occurs":[5],"in":[6,27,59,104,132,540,571,593,644],"approximately":[7],"5-15%":[8],"of":[9,29,57,69,110,277,280,318,333,336,372,423,445,457,466,485,530,543,662,669],"patients":[10,645],"(pts)":[11],"with":[12,20,61,66,85,116,122,138,150,157,166,179,246,414,566,576,646],"advanced":[13,339],"breast":[14],"cancer":[15],"(ABC)":[16],"and":[17,23,41,55,63,106,177,228,232,235,237,287,324,345,387,392,430,462,506,517,546,573,653],"is":[18,51,92],"associated":[19],"poor":[21],"survival":[22,209,215],"a":[24,67,93,463,550],"significant":[25],"reduction":[26],"quality":[28],"life.":[30],"The":[31,476],"antibody-drug":[32],"conjugate":[33],"trastuzumab":[34],"deruxtecan":[35],"(T-DXd)":[36],"has":[37],"shown":[38],"remarkable":[39],"intracranial":[40,419],"extracranial":[42,315,428],"activity,":[43],"leading":[44],"to":[45,224,268,473,588],"its":[46],"widespread":[47],"clinical":[48,219,435],"use.":[49],"DEBBRAH":[50,90,664],"evaluating":[52],"the":[53,247,274,408,523,590,663,670],"efficacy":[54],"safety":[56,236,569],"T-DXd":[58,188,562],"pts":[60,84,112,265,292,307,312,327,381,413,426,447,575],"HER2[+]":[62,118,136,146,155,173,386,572,647],"HER2-low":[64,120,148,164,175,574],"ABC":[65,121,137,149,156,165,176],"history":[68],"brain":[70],"metastases":[71],"(BM)":[72],"and/or":[73,128,143],"LMC.":[74,88,581],"Here,":[75],"we":[76],"report":[77],"results":[78],"from":[79,659],"cohort":[80,205,296],"5":[81,133,206,412,443,661],"that":[82,263],"included":[83,213],"pathologically":[86,579],"confirmed":[87,580],"Methods:":[89],"(NCT04420598)":[91],"single-arm,":[94],"open-label,":[95],"five-cohort,":[96],"phase":[97],"2":[98,317],"study":[99],"conducted":[100],"across":[101],"18":[102],"sites":[103],"Spain":[105],"Portugal.":[107],"A":[108,421],"total":[109,422],"39":[111],"aged":[113],"\u226518":[114],"years":[115],"pretreated":[117],"or":[119,125,147,174,199,648],"stable,":[123],"progressing,":[124],"untreated":[126,152],"BM":[127,140,159,168],"LMC":[129,178],"were":[130,293,308,440,489,522,534,559],"enrolled":[131],"cohorts:":[134],"(1)":[135],"non-progressing":[139],"after":[141,160,169,390],"radiotherapy":[142],"surgery;":[144],"(2)":[145],"asymptomatic":[151],"BM;":[153],"(3)":[154],"progressing":[158,167],"local":[161,170,350],"treatment;":[162,171],"(4)":[163],"(5)":[172],"positive":[180],"cerebrospinal":[181],"fluid":[182],"cytology.":[183],"Pts":[184],"received":[185,348],"5.4":[186],"mg/kg":[187],"intravenously":[189],"once":[190],"every":[191],"21":[192],"days":[193],"until":[194],"disease":[195,340,415],"progression,":[196,416],"unacceptable":[197],"toxicity,":[198],"consent":[200],"withdrawal.":[201],"Primary":[202],"endpoint":[203],"for":[204,338,352,453],"was":[207,244,300,341,365,374,399],"overall":[208,217,233,455],"(OS).":[210],"Secondary":[211],"endpoints":[212],"progression-free":[214],"(PFS),":[216],"response,":[218],"benefit":[220],"rate":[221,398],"(CBR)":[222],"according":[223,472],"RANO-BM":[225],"(intracranial":[226],"lesions)":[227],"RECIST":[229,474],"v.1.1":[230],"(extracranial":[231],"lesions);":[234],"tolerability":[238],"as":[239],"per":[240],"NCI-CTCAE":[241],"v.5.0.":[242],"OS":[243,254,397],"tested":[245],"maximum":[248],"likelihood":[249],"exponential":[250],"method":[251],"(H0:":[252],"median":[253,258,363,464],"\u22642":[255],"months;":[256],"H1:":[257],"OS\u22656":[259],"months).":[260],"We":[261],"estimate":[262],"7":[264,291,446,544],"are":[266],"needed":[267],"attain":[269],"an":[270,454],"80%":[271],"power":[272],"at":[273],"nominal":[275],"level":[276],"one-sided":[278],"\u03b1":[279],"0.05.":[281],"Results:":[282],"Between":[283],"Apr":[284,288],"14,":[285],"2021,":[286],"5,":[289],"2022,":[290],"allocated":[294],"into":[295],"5.":[297],"Median":[298,331,370,396],"age":[299],"57":[301],"(range,":[302,343,368,377],"42\u201369)":[303],"years,":[304],"3":[305,325],"(42.9%)":[306,326],"HER2[+],":[309],"6":[310],"(85.7%)":[311],"had":[313,328,418,434,448],"synchronous":[314],"metastases,":[316],"whom":[319],"(28.6%)":[320,380],"also":[321],"presented":[322,427],"BM,":[323],"measurable":[329],"disease.":[330],"number":[332],"previous":[334],"lines":[335],"therapy":[337],"4":[342,424,541],"1-8)":[344],"no":[346,567],"patient":[347,433,548],"prior":[349],"treatment":[351,373,480],"central":[353],"nervous":[354],"system":[355],"involvement.":[356],"At":[357],"data":[358,584],"cut-off":[359],"(Apr":[360],"4,":[361],"2023),":[362],"follow-up":[364],"12":[366],"months":[367,376,401,468],"2.5-18.6).":[369],"duration":[371],"9.0":[375],"2.1-18.6).":[378],"Two":[379],"remained":[382],"on":[383],"treatment:":[384],"1":[385,388,431,547],"HER2-low,":[389],"18.6":[391],"12.0":[393],"months,":[394],"respectively.":[395],"13.3":[400],"(95%":[402,459,469],"CI,":[403,460,470],"5.7-NA,":[404],"p<":[405],"0.001)":[406],"meeting":[407],"primary":[409],"endpoint.":[410],"Among":[411],"none":[417],"progression.":[420],"(57.1%)":[425,542],"progression":[429],"(14.3%)":[432],"worsening.":[436],"No":[437,528,556],"objective":[438],"responses":[439],"observed,":[441],"but":[442],"out":[444],"prolonged":[449],"stabilization":[450],"(\u226524":[451],"weeks)":[452],"CBR":[456],"71.4%":[458],"29.0-96.3)":[461],"PFS":[465],"8.9":[467],"4.9-NA)":[471],"v.1.1.":[475],"most":[477,524],"common":[478],"non-hematological":[479],"emergent":[481],"adverse":[482],"events":[483],"(TEAEs)":[484],"any":[486],"grade":[487],"(G)":[488],"nausea":[490],"(57.1%;":[491],"14.3%":[492,520],"G3),":[493,497,501,505],"fatigue":[494],"(42.9%;":[495,499,503,510,514],"0%":[496,500,504,511,515],"vomiting":[498],"headache":[502],"urinary":[507],"tract":[508],"infection":[509],"G3).":[512,555],"Anemia":[513],"G3)":[516,521],"thrombocytopenia":[518],"(28.6%;":[519],"frequent":[525],"hematological":[526],"TEAEs.":[527],"cases":[529],"interstitial":[531],"lung":[532],"disease/pneumonitis":[533],"reported.":[535,560],"Serious":[536],"unrelated":[537],"TEAEs":[538],"occurred":[539],"pts,":[545],"experienced":[549],"related":[551],"serious":[552],"TEAE":[553],"(nausea":[554],"treatment-related":[557],"deaths":[558],"Conclusions:":[561],"showed":[563],"promising":[564],"activity":[565],"new":[568],"concerns":[570],"previously":[577],"untreated,":[578],"These":[582],"encouraging":[583],"warrant":[585],"further":[586],"investigation":[587],"address":[589],"unmet":[591],"need":[592],"this":[594],"difficult-to-treat":[595],"condition.":[596],"Citation":[597],"Format:":[598],"Marta":[599],"Vaz":[600],"Batista,":[601],"Jos\u00e9":[602,607],"Manuel":[603,616],"P\u00e9rez-Garc\u00eda,":[604],"Laia":[605],"Garrig\u00f3s,":[606],"\u00c1ngel":[608],"Garc\u00eda-S\u00e1enz,":[609],"Patricia":[610],"Cortez-Castedo,":[611],"Fabriccio":[612],"Racca,":[613],"Salvador":[614],"Blanch,":[615],"Ru\u00edz":[617],"-":[618],"Borrego,":[619],"Adela":[620],"Fern\u00e1ndez,":[621],"Mar\u00eda":[622],"Fern\u00e1ndez-Abad,":[623],"Vega":[624],"Iranzo,":[625],"Maria":[626],"Gion,":[627],"Griselda":[628],"Martrat,":[629],"Daniel":[630],"Alcal\u00e1-L\u00f3pez,":[631],"Jhudit":[632],"P\u00e9rez-Escuredo,":[633],"Miguel":[634],"Sampayo-Cordero,":[635],"Antonio":[636,673],"Llombart-Cussac,":[637],"Sof\u00eda":[638],"Braga,":[639],"Javier":[640],"Cort\u00e9s.":[641],"Trastuzumab":[642],"Deruxtecan":[643],"HER2-Low":[649],"Advanced":[650],"Breast":[651,674],"Cancer":[652,675,686],"Pathologically":[654],"Confirmed":[655],"Carcinomatosis:":[657],"Results":[658],"Cohort":[660],"Study":[665],"[abstract].":[666],"In:":[667],"Proceedings":[668],"2023":[671,677],"San":[672,680],"Symposium;":[676],"Dec":[678],"5-9;":[679],"Antonio,":[681],"TX.":[682],"Philadelphia":[683],"(PA):":[684],"AACR;":[685],"Res":[687],"2024;84(9":[688],"Suppl):Abstract":[689],"nr":[690],"PS11-05.":[691]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":5}],"updated_date":"2026-10-16T09:59:22.235173","created_date":"2024-05-03T00:00:00"}